![Anti-CD19 chimeric antigen receptor T cells secreting anti-PD-L1 single-chain variable fragment attenuate PD-L1 mediated T cell inhibition - ScienceDirect Anti-CD19 chimeric antigen receptor T cells secreting anti-PD-L1 single-chain variable fragment attenuate PD-L1 mediated T cell inhibition - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1567576922009274-ga1.jpg)
Anti-CD19 chimeric antigen receptor T cells secreting anti-PD-L1 single-chain variable fragment attenuate PD-L1 mediated T cell inhibition - ScienceDirect
![Expression of CD5 and CD19 markers in B-cells of patients with chronic... | Download Scientific Diagram Expression of CD5 and CD19 markers in B-cells of patients with chronic... | Download Scientific Diagram](https://www.researchgate.net/publication/313463302/figure/fig1/AS:459503008260099@1486565463178/Expression-of-CD5-and-CD19-markers-in-B-cells-of-patients-with-chronic-lymphocytic.png)
Expression of CD5 and CD19 markers in B-cells of patients with chronic... | Download Scientific Diagram
![Treating B-cell cancer with T cells expressing anti-CD19 chimeric antigen receptors | Nature Reviews Clinical Oncology Treating B-cell cancer with T cells expressing anti-CD19 chimeric antigen receptors | Nature Reviews Clinical Oncology](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fnrclinonc.2013.46/MediaObjects/41571_2013_Article_BFnrclinonc201346_Fig1_HTML.jpg)
Treating B-cell cancer with T cells expressing anti-CD19 chimeric antigen receptors | Nature Reviews Clinical Oncology
of CD19 and CD20 expression during B cell development. CD19 expression... | Download Scientific Diagram
![CD19: a biomarker for B cell development, lymphoma diagnosis and therapy | Experimental Hematology & Oncology | Full Text CD19: a biomarker for B cell development, lymphoma diagnosis and therapy | Experimental Hematology & Oncology | Full Text](https://media.springernature.com/m685/springer-static/image/art%3A10.1186%2F2162-3619-1-36/MediaObjects/40164_2012_Article_34_Fig2_HTML.jpg)
CD19: a biomarker for B cell development, lymphoma diagnosis and therapy | Experimental Hematology & Oncology | Full Text
![Screening for CD19-specific chimaeric antigen receptors with enhanced signalling via a barcoded library of intracellular domains | Nature Biomedical Engineering Screening for CD19-specific chimaeric antigen receptors with enhanced signalling via a barcoded library of intracellular domains | Nature Biomedical Engineering](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41551-022-00896-0/MediaObjects/41551_2022_896_Fig1_HTML.png)
Screening for CD19-specific chimaeric antigen receptors with enhanced signalling via a barcoded library of intracellular domains | Nature Biomedical Engineering
![Single-cell profiling identifies pre-existing CD19-negative subclones in a B-ALL patient with CD19-negative relapse after CAR-T therapy | Nature Communications Single-cell profiling identifies pre-existing CD19-negative subclones in a B-ALL patient with CD19-negative relapse after CAR-T therapy | Nature Communications](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41467-021-21168-6/MediaObjects/41467_2021_21168_Fig1_HTML.png)
Single-cell profiling identifies pre-existing CD19-negative subclones in a B-ALL patient with CD19-negative relapse after CAR-T therapy | Nature Communications
![Single-Cell Analyses Identify Brain Mural Cells Expressing CD19 as Potential Off-Tumor Targets for CAR-T Immunotherapies - ScienceDirect Single-Cell Analyses Identify Brain Mural Cells Expressing CD19 as Potential Off-Tumor Targets for CAR-T Immunotherapies - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0092867420310138-fx1.jpg)
Single-Cell Analyses Identify Brain Mural Cells Expressing CD19 as Potential Off-Tumor Targets for CAR-T Immunotherapies - ScienceDirect
![CD19: a biomarker for B cell development, lymphoma diagnosis and therapy | Experimental Hematology & Oncology | Full Text CD19: a biomarker for B cell development, lymphoma diagnosis and therapy | Experimental Hematology & Oncology | Full Text](https://media.springernature.com/m685/springer-static/image/art%3A10.1186%2F2162-3619-1-36/MediaObjects/40164_2012_Article_34_Fig1_HTML.jpg)
CD19: a biomarker for B cell development, lymphoma diagnosis and therapy | Experimental Hematology & Oncology | Full Text
![Expression of a Novel Chimeric Inhibitory Receptor Attenuates CD19 CAR T Cells: A Promising Strategy for Toxicity Mitigation - Transplantation and Cellular Therapy, Official Publication of the American Society for Transplantation and Expression of a Novel Chimeric Inhibitory Receptor Attenuates CD19 CAR T Cells: A Promising Strategy for Toxicity Mitigation - Transplantation and Cellular Therapy, Official Publication of the American Society for Transplantation and](https://www.astctjournal.org/cms/asset/797dc693-6748-4743-b11c-0b0c6ad7d745/gr5.jpg)